Literature DB >> 2451660

Transforming growth factor beta modulates epidermal growth factor-induced phosphoinositide metabolism and intracellular calcium levels.

L L Muldoon1, K D Rodland, B E Magun.   

Abstract

Transforming growth factor beta (TGF beta) alters the cellular response to epidermal growth factor (EGF) in a number of systems, but the underlying mechanisms for these alterations are largely unknown. We have examined second messenger formation in Rat-1 cells following treatment with EGF and/or TGF beta to determine whether the ability of TGF beta to potentiate some EGF-stimulated processes might be mediated by TGF beta-induced alterations in the signal transduction mechanism. Incubation of serum-deprived confluent Rat-1 cells with 10 ng/ml TGF beta resulted in a marked elevation of cellular inositol trisphosphate and inositol tetrakisphosphate levels, which were maximal at 4 h and maintained for at least 8 h. The effect of TGF beta on levels of inositol trisphosphate and inositol tetrakisphosphate was blocked by actinomycin D, suggesting that RNA synthesis was required for the TGF beta effect. While EGF stimulation induced a rapid and transient (5 min) rise in inositol phosphate levels in control cells, the EGF effect was considerably increased, both in magnitude and duration, by TGF beta treatment. Measurement of intracellular free Ca2+ with fura-2 demonstrated that TGF beta treatment markedly increased the EGF-stimulated rise in free Ca2+ and increased the duration of the response. The positive effects of TGF beta on EGF stimulation could not be explained on the basis of increased EGF binding to cells. We conclude that TGF beta treatment can both activate phosphatidylinositol turnover independently and also sensitize Rat-1 cells to stimulation by EGF.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2451660

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  6 in total

1.  Signal transduction of a tissue interaction during embryonic heart development.

Authors:  R B Runyan; J D Potts; R V Sharma; C P Loeber; J J Chiang; R C Bhalla
Journal:  Cell Regul       Date:  1990-02

2.  Transforming growth factor-β receptors.

Authors:  P R Segarini
Journal:  Cytotechnology       Date:  1989-12       Impact factor: 2.058

3.  Transforming growth factor beta 1 inhibits mitogen-activated protein kinase induced by basic fibroblast growth factor in smooth muscle cells.

Authors:  E Berrou; M Fontenay-Roupie; R Quarck; F R McKenzie; S Lévy-Toledano; G Tobelem; M Bryckaert
Journal:  Biochem J       Date:  1996-05-15       Impact factor: 3.857

4.  Transforming growth factor beta 1, a potent chemoattractant for human neutrophils, bypasses classic signal-transduction pathways.

Authors:  J Reibman; S Meixler; T C Lee; L I Gold; B N Cronstein; K A Haines; S L Kolasinski; G Weissmann
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-01       Impact factor: 11.205

5.  Modulation of phospholipase A2 activity by epidermal growth factor (EGF) in CHO cells transfected with human EGF receptor. Role of receptor cytoplasmic subdomain.

Authors:  S Clark; M Dunlop
Journal:  Biochem J       Date:  1991-03-15       Impact factor: 3.857

6.  Effect of Cyclosporin A and Angiotensin II on cytosolic calcium levels in primary human gingival fibroblasts.

Authors:  Ajitkumar Supraja; Murugan Girija Dinesh; Subbarayan Rajasekaran; Thodur Madapusi Balaji; Suresh Ranga Rao
Journal:  Dent Res J (Isfahan)       Date:  2016-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.